NEXGEL INC (NXGL) Stock Price & Overview
NASDAQ:NXGL • US65344E1073
Current stock price
The current stock price of NXGL is 0.6108 USD. Today NXGL is down by -5.6%. In the past month the price decreased by -9.55%. In the past year, price decreased by -75.86%.
NXGL Key Statistics
- Market Cap
- 5.18M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.38
- Dividend Yield
- N/A
NXGL Stock Performance
NXGL Stock Chart
NXGL Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to NXGL. When comparing the yearly performance of all stocks, NXGL is a bad performer in the overall market: 98.09% of all stocks are doing better.
NXGL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to NXGL. NXGL may be in some trouble as it scores bad on both profitability and health.
NXGL Earnings
On April 8, 2026 NXGL reported an EPS of -0.12 and a revenue of 2.80M. The company missed EPS expectations (-30.72% surprise) and missed revenue expectations (-15.4% surprise).
NXGL Forecast & Estimates
7 analysts have analysed NXGL and the average price target is 2.04 USD. This implies a price increase of 233.99% is expected in the next year compared to the current price of 0.6108.
For the next year, analysts expect an EPS growth of 83.89% and a revenue growth 42.29% for NXGL
NXGL Groups
Sector & Classification
NXGL Financial Highlights
Over the last trailing twelve months NXGL reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -28.68% | ||
| ROE | -67.28% | ||
| Debt/Equity | 0.16 |
NXGL Ownership
NXGL Latest News, Press Relases and Analysis
NXGL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| MDLN | MEDLINE INC-CL A | 30.82 | 60.732B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.55 | 13.656B | ||
| COO | COOPER COS INC/THE | 12.8 | 12.672B | ||
| SOLV | SOLVENTUM CORP | 10.47 | 11.958B | ||
| LNTH | LANTHEUS HOLDINGS INC | 15.63 | 5.381B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 16.6 | 4.093B | ||
| ICUI | ICU MEDICAL INC | 15.05 | 3.113B | ||
| HAE | HAEMONETICS CORP/MASS | 11.25 | 2.771B | ||
| XRAY | DENTSPLY SIRONA INC | 8.15 | 2.377B | ||
| NEOG | NEOGEN CORP | 27.57 | 2.035B | ||
| UFPT | UFP TECHNOLOGIES INC | 19.66 | 1.527B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.23B | ||
| AVNS | AVANOS MEDICAL INC | 24.2 | 1.149B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NXGL
Company Profile
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
Company Info
IPO: 2021-12-22
NEXGEL INC
2150 Cabot Blvd West,, Suite B
Langhorne PENNSYLVANIA US
Employees: 19
Phone: 12157028550
NEXGEL INC / NXGL FAQ
What does NEXGEL INC do?
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
What is the stock price of NEXGEL INC today?
The current stock price of NXGL is 0.6108 USD. The price decreased by -5.6% in the last trading session.
What is the dividend status of NEXGEL INC?
NXGL does not pay a dividend.
What is the ChartMill rating of NEXGEL INC stock?
NXGL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
On which exchange is NXGL stock listed?
NXGL stock is listed on the Nasdaq exchange.
What is the analyst forecast for NXGL stock?
7 analysts have analysed NXGL and the average price target is 2.04 USD. This implies a price increase of 233.99% is expected in the next year compared to the current price of 0.6108.
What is the outstanding short interest for NEXGEL INC?
The outstanding short interest for NEXGEL INC (NXGL) is 1.18% of its float.